Receptor Tyrosine Kinases as Therapeutic Targets the Model of the MET Oncogene
Journal:
Current Drug Targets
Volume:
2
Page:
41-55
Author(s):
Paola Longati, Paolo M. Comoglio and Alberto Bardelli
Signal Transduction Pathways and Transcriptional Mechanisms as Targets for Prevention of Emergence of Multidrug Resistance in Human Cancer Cells
Journal:
Current Drug Targets
Volume:
2
Page:
57-77
Author(s):
Alexander A. Shtil
Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
19-46
Author(s):
Revital Niv, Cyril J. Cohen, Galit Denkberg, Dina Segal and Yoram Reiter
The Mouse In Cancer Research Past, Present, Future
Journal:
Current Genomics
Volume:
2
Page:
1-26
Author(s):
K. Hunter and D. Cozma
Bestatin as an Experimental Tool in Mammals
Journal:
Current Drug Metabolism
Volume:
2
Page:
67-85
Author(s):
O. A. Scornik and V. Botbol
Biodistribution of Radiolabeled [ 3 H] CMT-3 in Rats
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
253-256
Author(s):
J. Chen, M. Bookbinder, M. E. Ryan, L. M. Golub, R. Ashley and N. S. Ramamurthy
Biological Properties of Citrus Flavonoids Pertaining to Cancer and Inflammation
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
135-153
Author(s):
John A. Manthey, Najla Guthrie and Karel Grohmann
Recent Developments of Rebeccamycin Analogues as Topoisomerase I Inhibitors and Antitumor Agents.
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
1189-1212
Author(s):
Michelle Prudhomme
Antitumor Potential and Possible Targets of Phenothiazine-Related Compounds
Journal:
Current Drug Targets
Volume:
1
Page:
237-246
Author(s):
Noboru Motohashi, Masami Kawase, Setsuo Saito and Hiroshi Sakagami
Membrane Transporters and Antifungal Drug Resistance
Journal:
Current Drug Targets
Volume:
1
Page:
261-284
Author(s):
Vassil St. Georgiev